Abstract | BACKGROUND AND AIM: METHODS: RESULTS: We developed a mouse model of AIG with early onset and rapid progression in which neonatal thymectomy (NTx) was performed on programmed cell death 1-deficient (PD-1(-/-) ) mice on the BALB/c background. Using NTx-PD-1(-/-) mice, we found that in AIG lesions, interferon-γ, and tumor necrosis factor (TNF)-α together with interleukin-21 (IL-21) were highly expressed in the inflamed gastric mucosa. In addition, as with the injection of dexamethasone, in vivo administration of either anti-TNF-α or anti-IL-21 suppressed the development of AIG in NTx-PD-1(-/-) mice. CONCLUSIONS: These data reveal the essential role of IL-21 in the development of AIG and suggest that in addition to corticosteroids, anti-TNF-α as well as anti-IL-21 have the potential to induce the remission of AIG, offering additional therapeutic options for AIG patients.
|
Authors | Hisayo Nishiura, Satoru Iwamoto, Masahiro Kido, Nobuhiro Aoki, Ryutaro Maruoka, Aki Ikeda, Tsutomu Chiba, Norihiko Watanabe |
Journal | Journal of gastroenterology and hepatology
(J Gastroenterol Hepatol)
Vol. 28
Issue 6
Pg. 982-91
(Jun 2013)
ISSN: 1440-1746 [Electronic] Australia |
PMID | 23425147
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | © 2013 Journal of Gastroenterology and Hepatology Foundation and Wiley Publishing Asia Pty Ltd. |
Chemical References |
- Interleukins
- Tumor Necrosis Factor-alpha
- interleukin-21
|
Topics |
- Animals
- Autoimmune Diseases
(immunology)
- Gastritis
(immunology)
- Interleukins
(immunology)
- Mice
- Mice, Inbred BALB C
- Tumor Necrosis Factor-alpha
(immunology)
|